Literature DB >> 30178488

Anatomical analysis of gastric lymph nodes in cancer-free individuals.

Fernando A M Herbella1, Laercio G Lourenço1, Andre L Bonini1, Francisco Schlottmann2, Marco G Patti2.   

Abstract

Lymphadenectomy is a crucial part of the surgical therapy for gastric cancer. The number of normal lymph nodes could indicate the number of nodes that need to be retrieved during the procedure. The aim of this study is to analyze the number of lymph nodes in cadavers without gastric cancer according to the Japanese Gastric Cancer Association guidelines. Twenty fresh adult cadavers (14 males, mean age 55, range 24-93 years) were used. Abdominal lymph nodes were dissected and classified according to the Japanese Gastric Cancer Association. For total gastrectomy, the median number of lymph nodes that comprised D1 + dissection was 27 (range 15-42). The median and mean number of lymph nodes that comprised D2 dissection was 33, ranging from 18 to 50. For distal gastrectomy, the D1 + level comprised a median of 21 lymph nodes (range 11-38), and the D2 level 22 lymph nodes (range 11-39). In conclusion, considering gastrectomy + D2 lymphadenectomy as the standard treatment for gastric cancer, our results show that adequate lymphadenectomy must encompass around 30 lymph nodes. Clin. Anat., 2018.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  lymph node excision; lymph nodes; neoplasm staging; stomach neoplasms

Mesh:

Year:  2018        PMID: 30178488     DOI: 10.1002/ca.23241

Source DB:  PubMed          Journal:  Clin Anat        ISSN: 0897-3806            Impact factor:   2.414


  1 in total

1.  Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol.

Authors:  Giuseppe Malleo; Laura Maggino; Fabio Casciani; Gabriella Lionetto; Sara Nobile; Gianni Lazzarin; Salvatore Paiella; Alessandro Esposito; Paola Capelli; Claudio Luchini; Aldo Scarpa; Claudio Bassi; Roberto Salvia
Journal:  Ann Surg Oncol       Date:  2022-02-21       Impact factor: 4.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.